Assessing the Impact of High Body Mass Index (BMI) on the Efficacy of Assisted Reproductive Technologies (ART) in Saudi Women: A Cross-Sectional Study Examining Ovarian Reserve and Treatment Outcomes.
art
cycle numbers
high bmi
ivf & icsi
live births
ovarian
pcos
saudi women
treatment outcomes
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
accepted:
09
10
2023
medline:
29
11
2023
pubmed:
29
11
2023
entrez:
29
11
2023
Statut:
epublish
Résumé
The global surge in high body mass index (BMI) and obesity has led to various health complications. While numerous studies have shown that obesity disrupts female fertility, the specific effects of obesity on the success rate of assisted reproductive technology (ART) treatments in Saudi women have been less explored. This study aimed to delve into this gap, especially focusing on the correlation between BMI, ovarian reserve parameters, and ART outcomes among Saudi women. A cross-sectional study was carried out from January to August 2023, concentrating on Saudi women aged 18 and above who underwent ART treatments for infertility. A total of 1071 women participated, with 155 completing an online survey and 916 responding through a hard copy from several Saudi hospitals. The data encompassed demographics, medical history, anthropometric details, ovarian reserve parameters, and ART results. For the analysis, Statistical Package for the Social Sciences (IBM SPSS Statistics for Windows, IBM Corp., Version 28.0, Armonk, NY) was utilized, applying descriptive statistics, the Chi-square test, and a linear regression model to discern connections between BMI, participant characteristics, and ART outcomes. A p-value of less than 0.05 was considered statistically significant. Most participants were aged 25-34 (406) years and held a bachelor's degree (707). Over half (560) received fertility treatments in the past, with 37.9% (406) having polycystic ovary syndrome (PCOS) and 23.5% (252) with other fertility-impacting medical conditions. Interestingly, 62.1% (665) had not undergone any ART cycles. Of those who did, 51.6% (553) had clinical pregnancies leading to live births. About 23.8% (308) of those with clinical pregnancies faced miscarriages without successful live births. Furthermore, 17.6% (189) reported complications or side effects from past ART procedures, and 31.4% (336) were on ART-related medications or supplements. The linear regression highlighted that individuals with normal weight tended to undergo more ART cycles. However, those with a higher BMI exhibited increased chances of achieving clinical pregnancies and live births. The study underscores the crucial relationship between BMI and ART efficacy in Saudi women. The data reveals that BMI can significantly influence ART treatment outcomes, especially concerning the number of cycles, clinical pregnancies, and live births. Consequently, BMI should be an essential consideration when evaluating and optimizing the success rates of ART procedures.
Identifiants
pubmed: 38022012
doi: 10.7759/cureus.46706
pmc: PMC10630711
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e46706Informations de copyright
Copyright © 2023, Aleid et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Hum Reprod Sci. 2017 Jan-Mar;10(1):37-43
pubmed: 28479754
J Psychosom Obstet Gynaecol. 2019 Mar;40(1):2-18
pubmed: 29172958
Fertil Steril. 2006 Nov;86(5):1356-64
pubmed: 17070192
Healthcare (Basel). 2023 Apr 15;11(8):
pubmed: 37107976
Saudi Med J. 2021 Jun;42(6):666-672
pubmed: 34078730
Curr Opin Endocrinol Diabetes Obes. 2007 Dec;14(6):482-7
pubmed: 17982356
Curr Opin Obstet Gynecol. 2022 Jun 1;34(3):114-121
pubmed: 35645009
Int J Med Sci. 2023 Jan 31;20(3):366-375
pubmed: 36860674
World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253
pubmed: 11234459
Sci Rep. 2022 Nov 7;12(1):18858
pubmed: 36344718
Hum Reprod Update. 2007 Sep-Oct;13(5):433-44
pubmed: 17584821
BMC Womens Health. 2022 Nov 28;22(1):479
pubmed: 36443765